Why BMI Alone Doesn't Tell the Full Story

A 24.5 BMI earns a reassuring nod in a New York clinic. The same number in a Seoul clinic opens a conversation about pre-obesity, visceral fat, and metabolic screening. This isn't a quirk of local medical culture — it reflects nearly two decades of evidence that the numerical cutoffs built into the standard BMI chart were never designed for the populations they are most often used on.

A Formula Built for Belgians in 1832

Body Mass Index traces back to Adolphe Quetelet, a Belgian mathematician studying population averages. He never intended the ratio — weight in kilograms divided by height squared in meters — as a diagnostic tool for individuals. It was a statistical convenience, repackaged a century later by insurance actuaries and eventually adopted by the World Health Organization as the default screening instrument for overweight and obesity.

The appeal is obvious. The inputs are cheap, the math is trivial, and the output slots neatly into four bins: underweight, normal, overweight, obese. But a single ratio cannot distinguish lean mass from fat mass, nor subcutaneous fat from the visceral adipose tissue that wraps around the liver, pancreas, and mesentery. And visceral fat — not total body weight — is what drives insulin resistance, dyslipidemia, and cardiovascular risk.

The Asian BMI Problem

In 2004, a WHO expert consultation published in The Lancet formally acknowledged what clinicians across East and South Asia had been documenting for years. At any given BMI, Asian populations carry a higher percentage of body fat and substantially more visceral adipose tissue than White European reference populations. The result is that metabolic disease — type 2 diabetes, hypertension, fatty liver — appears at BMI values that Western guidelines still classify as perfectly healthy.

The numbers that emerged from that consultation are now embedded in clinical practice across the region. The WHO Asian-specific cut points define the normal range as 18.5–22.9, overweight as 23.0–27.4, and obese as 27.5 and above. Compare that with the standard chart — overweight at 25, obese at 30 — and the gap is roughly two BMI points at every boundary.

That gap is not academic. A 2021 population-based cohort study in The Lancet Diabetes & Endocrinology examined type 2 diabetes risk across ethnic groups in England and found that the equivalent BMI at which South Asian adults face the same diabetes risk as White adults at BMI 30 is approximately 23.9. For Black adults the figure was 28.1, and for Chinese adults 26.9. A single universal threshold collapses these differences and, in doing so, systematically underdiagnoses metabolic disease in the populations most affected by it.

For those curious about where they fall on region-specific scales, a BMI calculator calibrated to Asian-specific thresholds offers a more nuanced assessment than most generic tools still circulating online.

Heterogeneity the Pan-Asian Label Obscures

The picture gets more complicated once you look inside the "Asian" category. National guidelines across the region diverge: India uses 25 as the obesity threshold, China uses 28, Japan uses 25, and Korea uses 25 with an overweight cutoff of 23. A 2015 review in the Journal of Obesity on Asian Americans noted that within the 23.0–24.9 range, diabetes prevalence was markedly elevated in Filipino, Korean, South Asian, and Vietnamese adults but not in Chinese or Japanese adults. Lumping these populations together under a single "Asian BMI" produces averages that fit almost no one precisely.

This matters for how the numbers are used in individual care. An Indian-American patient with a BMI of 24 is, statistically, carrying cardiovascular risk that a generic WHO chart would miss entirely. A Japanese-American patient with the same BMI may not. The policy-level cutoffs are a starting point, not a verdict.

What BMI Fails to See

The "skinny fat" phenotype. A sedentary adult can register a BMI of 21 while carrying 32% body fat and almost no skeletal muscle. Fasting glucose is elevated. Triglycerides are climbing. The waist-to-hip ratio is abnormal. BMI registers none of it.

The muscular miscategorization. Strength athletes, rugby players, and anyone with serious resistance-training history routinely post BMIs of 27 to 29 while holding body fat percentages below 15%. The WHO chart labels them overweight. Their metabolic panels tell a different story.

Waist circumference as the missing variable. Central adiposity — measured simply with a tape around the navel — independently predicts type 2 diabetes and cardiovascular events across every BMI category. Korean guidelines flag waist circumference above 90 cm in men and 85 cm in women. The U.S. thresholds are 102 cm and 88 cm. Same physiology, different numbers, again reflecting the ethnic calibration problem.

Age-related shifts. Lean muscle declines by roughly 3–8% per decade after 30, accelerating after 60. An older adult can hold a stable BMI while losing muscle and gaining fat — a condition called sarcopenic obesity that standard BMI interpretation actively hides.

A Composite Approach

No single metric captures metabolic health. The direction of clinical research over the past decade points toward a layered assessment:

• BMI for initial screening, interpreted through the relevant ethnic cutoff
• Waist circumference or waist-to-height ratio (a ratio above 0.5 flags central adiposity regardless of ethnicity or sex)
• Body fat percentage from bioelectrical impedance or DEXA where available
• Fasting glucose and HbA1c to surface early insulin resistance
• Lipid panel — triglycerides, HDL, LDL, and the triglyceride-to-HDL ratio
• Blood pressure as the cardiovascular baseline

A BMI of 23 with a waist under 85 cm, normal fasting glucose, and a healthy lipid profile is a fundamentally different risk picture than the same BMI with abdominal obesity and borderline hypertension. The number on the scale doesn't change. Everything it means does.

Reading Your Own Numbers

If your BMI has ever been described as "fine," treat it as a prompt to ask the next question. What is your waist circumference? When was your last fasting glucose? What is your HDL, and how does it compare to your triglycerides? If your ancestry is East Asian, South Asian, or Southeast Asian, pay particular attention to the 23.0–24.9 range — the zone that Western guidelines call normal and Asian guidelines flag as elevated risk.

The goal isn't to manufacture anxiety over numbers. It's to stop letting a formula designed in 1832 for Belgian statistics be the final word on individual health in 2026.

Sarah Chen is the Nutrition Editor at HealthKoLab. She is a Registered Dietitian Nutritionist with a Master's in Nutritional Science from UC Davis.